Gadler F - Search Results

1

Causes of death and mortality in hypertrophic cardiomyopathy patients with implantable defibrillators in Sweden.

Magnusson P, Gadler F, Liv P, Mörner S. Magnusson P, et al. Among authors: gadler f. J Cardiovasc Med (Hagerstown). 2016 Jul;17(7):478-84. doi: 10.2459/JCM.0000000000000359. J Cardiovasc Med (Hagerstown). 2016. PMID: 26808417

2

The European cardiac resynchronization therapy survey.

Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, Limbourg T, Linde C, van Veldhuisen DJ, Brugada J; Scientific Committee; National Coordinators. Dickstein K, et al. Eur Heart J. 2009 Oct;30(20):2450-60. doi: 10.1093/eurheartj/ehp359. Epub 2009 Aug 31. Eur Heart J. 2009. PMID: 19723694

3

Pacing-induced electrophysiological remodeling in hypertrophic obstructive cardiomyopathy--observations on cardiac memory.

Nowinski K, Wecke L, Gadler F, Linde C, Bergfeldt L. Nowinski K, et al. Among authors: gadler f. Pacing Clin Electrophysiol. 2005 Jun;28(6):561-7. doi: 10.1111/j.1540-8159.2005.09469.x. Pacing Clin Electrophysiol. 2005. PMID: 15955190

4

Women have better long-term prognosis than men after cardiac resynchronization therapy.

Zabarovskaja S, Gadler F, Braunschweig F, Ståhlberg M, Hörnsten J, Linde C, Lund LH. Zabarovskaja S, et al. Among authors: gadler f. Europace. 2012 Aug;14(8):1148-55. doi: 10.1093/europace/eus039. Epub 2012 Mar 7. Europace. 2012. PMID: 22399204

5

Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.

Gadler F, Valzania C, Linde C. Gadler F, et al. Europace. 2015 Jan;17(1):69-77. doi: 10.1093/europace/euu233. Epub 2014 Oct 21. Europace. 2015. PMID: 25336667

6

Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery.

Magnusson P, Gadler F, Liv P, Mörner S. Magnusson P, et al. Among authors: gadler f. J Cardiovasc Electrophysiol. 2015 Oct;26(10):1088-94. doi: 10.1111/jce.12750. Epub 2015 Sep 2. J Cardiovasc Electrophysiol. 2015. PMID: 26178879

7

Risk Markers and Appropriate Implantable Defibrillator Therapy in Hypertrophic Cardiomyopathy.

Magnusson P, Gadler F, Liv P, Mörner S. Magnusson P, et al. Among authors: gadler f. Pacing Clin Electrophysiol. 2016 Mar;39(3):291-301. doi: 10.1111/pace.12801. Epub 2016 Jan 21. Pacing Clin Electrophysiol. 2016. PMID: 26681505

8

Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators.

Magnusson P, Mörner S, Gadler F, Karlsson J. Magnusson P, et al. Among authors: gadler f. Health Qual Life Outcomes. 2016 Apr 14;14:62. doi: 10.1186/s12955-016-0467-x. Health Qual Life Outcomes. 2016. PMID: 27079917 Free PMC article.

9

Clinical risk profile score predicts all cause mortality but not implantable cardioverter defibrillator intervention rate in a large unselected cohort of patients with congestive heart failure.

Sjöblom J, Borgquist R, Gadler F, Kalm T, Ljung L, Rosenqvist M, Frykman V, Platonov PG. Sjöblom J, et al. Among authors: gadler f. Ann Noninvasive Electrocardiol. 2017 May;22(3):e12414. doi: 10.1111/anec.12414. Epub 2016 Nov 1. Ann Noninvasive Electrocardiol. 2017. PMID: 27800644 Free PMC article.

10

Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.

Boriani G, Merino J, Wright DJ, Gadler F, Schaer B, Landolina M. Boriani G, et al. Among authors: gadler f. Europace. 2018 Dec 1;20(12):1882-1897. doi: 10.1093/europace/euy066. Europace. 2018. PMID: 29757390 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters